In January 2026, select corporate brands delivered standout growth per...
“Customs duty exemptions on 17 select high-impact medicines anno...
“Budget 2026 marks a defining inflection point for India pharma&...
“The Indian biosimilar market is clearly moving beyond a launch-...
The Hormones therapy segment continues to stand out in the Indian phar...
Chief Minister (CM) Yogi Adityanath inaugurated the global congregatio...
Global pharma major Lupin has announced a strategic collaboration with...
AstraZeneca Pharma India has announced the Central Drugs Standard Cont...
The Government of India has announced the implementation of the four L...
Current Bisosimilars landscape in India India’s biosimilars lan...
Mumbai-based Sun Pharmaceutical Industries has received approval from ...
Ahmedabad-based Zydus Lifesciences has launched the world’s firs...
Mumbai-headquartered pharma major Lupin Limited has announced a licens...
Chhattisgarh is stepping up efforts to position itself as a leading ph...
The Indian anti-obesity market has witnessed a sharp acceleration sinc...
The anti-diabetes segment continues to reinforce its strategic importa...
The Indian pharmaceutical market (IPM) continues to demonstrate robust...
Within the Indian pharmaceutical market (IPM) the gastro intestinal th...
